
BLIS Technologies Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BLIS Technologies Limited
Access all reports
BLIS Technologies Limited is a biotechnology company specializing in the development and production of probiotic products for oral health. The company’s product range includes probiotics aimed at supporting throat health, immune function, and the balance of oral microbiota. Using proprietary bacterial strains, BLIS Technologies develops formulations available in lozenges, powders, and other formats for consumer health. The company’s products are distributed through health stores, pharmacies, and online channels in New Zealand. The company is headquartered in Dunedin, New Zealand, and its shares are listed on the NZX.
Key slides for BLIS Technologies Limited


AGM 2024
BLIS Technologies Limited


AGM 2024
BLIS Technologies Limited
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
BLT
Country
🇳🇿 New Zealand